Inventor · disambiguated record
Roderick Alan Porter
Also filed as: PORTER RODERICK · PORTER RODERICK A · PORTER RODERICK ALAN
40 granted patents·28 pending applications·261 citations·filing 1986–2025
97Inventor score
Files withSMITHKLINE BEECHAM PLC20GLAXO GROUP LTD9SMITHKLINE BEECHAM LTD7COULTON STEVEN4SEARLE & CO3
Top patents by PatentIndex Score
68 records- 0184US7943645B2Piperidine compounds for use as orexin receptor antagonistSMITHKLINE BEECHAM LTD·Filed 2008·Granted May 17, 2011·7 cites·8 claims
- 0284US4804658AImidazopyridine derivatives and pharmaceutical compositionsSEARLE & CO·Filed 1986·Granted Feb 14, 1989·33 cites·87 claims
- 0383US4837333ASubstituted alkylidene imidazolesSEARLE & CO·Filed 1987·Granted Jun 6, 1989·19 cites·2 claims
- 0479US7468367B2Ethylene diamine derivatives and their use as orexin-receptor antagonistsSMITHKLINE BEECHAM PLC·Filed 2002·Granted Dec 23, 2008·15 cites·15 claims
- 0579US6596730B1Phenyl urea and phenyl thiourea derivativesSMITHKLINE BEECHAM PLC·Filed 2000·Granted Jul 22, 2003·15 cites·3 claims
- 0678US7423052B2Piperidine compounds for use as orexin receptor antagoinstSMITHKLINE BEECHAM PLC·Filed 2002·Granted Sep 9, 2008·11 cites·15 claims
- 0777US7741329B2N-aroyl cyclic aminesSMITHKLINE BEECHAM LTD·Filed 2007·Granted Jun 22, 2010·2 cites·13 claims
- 0876US11298345B2Compounds that modulates AMPA receptor functionUNIV COLLEGE CARDIFF CONSULTANTS LTD·Filed 2019·Granted Apr 12, 2022·1 cites·23 claims
- 0976US7745642B2Glycine transport inhibitorsGLAXO GROUP LTD·Filed 2005·Granted Jun 29, 2010·4 cites·13 claims
- 1074US7432270B2N-aroyl cyclic aminesSMITHKLINE BEECHAM PLC·Filed 2002·Granted Oct 7, 2008·6 cites·13 claims
- 1174US2025375432A1Compounds that modulates ampa receptor functionUNIV COLLEGE CARDIFF CONSULTANTS LTD·Filed 2025·Application pending·0 cites
- 1273US7893090B2N-aroyl cyclic amine derivatives as orexin receptor antagonistsSMITHKLINE BEECHAM LTD·Filed 2007·Granted Feb 22, 2011·1 cites·11 claims
- 1371US12383540B2Compounds that modulates AMPA receptor functionUNIV COLLEGE CARDIFF CONSULTANTS LTD·Filed 2022·Granted Aug 12, 2025·0 cites·75 claims
- 1471US7470710B2N-aroyl cyclic amine derivatives as orexin receptor antagonistsSMITHKLINE BEECHAM PLC·Filed 2002·Granted Dec 30, 2008·4 cites·17 claims
- 1571US7078565B2Benzamide derivatives as antagonists of orexin receptorsSMITHKLINE BEECHAM PLC·Filed 2002·Granted Jul 18, 2006·7 cites·25 claims
- 1669US6699879B1Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonistsSMITHKLINE BEECHAM PLC·Filed 2000·Granted Mar 2, 2004·5 cites·20 claims
- 1768US5637593ATryptamine analogues as 5-ht1-like agonistsSMITHKLINE BEECHAM PLC·Filed 1993·Granted Jun 10, 1997·24 cites·11 claims
- 1867US6372757B1Phenylurea and phenylthio urea derivativesSMITHKLINE BEECHAM PLC·Filed 1999·Granted Apr 16, 2002·25 cites·11 claims
- 1963US7928125B2N-aroyl cyclic amine derivatives as orexin receptor antagonistsSMITHKLINE BEECHAM LTD·Filed 2007·Granted Apr 19, 2011·0 cites·8 claims
- 2063US7928124B2N-aroyl cyclic amine derivatives as orexin receptor antagonistsSMITHKLINE BEECHAM LTD·Filed 2007·Granted Apr 19, 2011·0 cites·6 claims
- 2163US7897618B2N-aroyl cyclic amine derivatives as orexin receptor antagonistsSMITHKLINE BEECHAM LTD·Filed 2007·Granted Mar 1, 2011·0 cites·7 claims
- 2260US7919507B2N-aroyl cyclic aminesSMITHKLINE BEECHAM LTD·Filed 2007·Granted Apr 5, 2011·0 cites·8 claims
- 2358US9193689B23-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic useCANCER RES INST ROYAL·Filed 2013·Granted Nov 24, 2015·1 cites·30 claims
- 2458US6410529B1Phenyl urea and phenyl thiourea derivatives as HFGAN72 antagonistsSMITHKLINE BEECHAM PLC·Filed 1998·Granted Jun 25, 2002·17 cites·12 claims
- 2556US5618947AProcess of preparing enantiomers of carbazole derivativesSMITHKLINE BEECHAM PLC·Filed 1993·Granted Apr 8, 1997·10 cites·5 claims
- 2655US5618948AProcess for preparing an enantiomer of a carbazole derivativeSMITHKLINE BEECHAM PLC·Filed 1995·Granted Apr 8, 1997·6 cites·1 claims
- 2753US12247011B2Selective inhibitors of NLRP3 inflammasomeNODTHERA LTD·Filed 2018·Granted Mar 11, 2025·0 cites·18 claims
- 2853US2025223263A1Selective inhibitors of nlrp3 inflammasomeNODTHERA LTD·Filed 2025·Application pending·0 cites
- 2952US12503475B2Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonistsCENTESSA PHARMACEUTICALS UK LTD·Filed 2021·Granted Dec 23, 2025·0 cites·20 claims
- 3051US6274594B1Isoquinoline derivatives and their therapeutical useSMITHKLINE BEECHAM PLC·Filed 1998·Granted Aug 14, 2001·9 cites·8 claims
- 3149US6248754B1Substituted isoquinoline derivatives and their use as anticonvulsantsSMITHKLINE BEECHAM PLC·Filed 1998·Granted Jun 19, 2001·8 cites·13 claims
- 3248US5650426AEnantiomers of carbazole derivatives as 5-HT.sub. 1-like agonistsSMITHKLINE BEECHAM PLC·Filed 1995·Granted Jul 22, 1997·6 cites·6 claims
- 3348US5616603AEnantiomers of carbazole derivatives as 5-HT1 -like agonistsSMITHKLINE BEECHAM PLC·Filed 1995·Granted Apr 1, 1997·9 cites·12 claims
- 3448US2002120139A1Pyrimidinone compounds and pharmaceutical compositions containing themFiled 2002·Application pending·0 cites
- 3548US2010113545A1Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disordersCOULTON STEVEN·Filed 2008·Application pending·0 cites
- 3647US6417192B1Pyrimidinone compounds and pharmaceutical compositions containing themSMITHKLINE BEECHAM PLC·Filed 1998·Granted Jul 9, 2002·6 cites·17 claims
- 3746US2010317704A1Spiro-condensed imidazolone derivatives inhibiting the glycine transporterGLAXO GROUP LTD A CORP·Filed 2008·Application pending·0 cites
- 3846US2010105713A1GLYT1 Transporter Inhibitors and Uses Thereof in Treatment of Neurological and Neuropsychiatric DisordersGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 3946US2009175788A1Radiolabelled ligand for the glycine 1 transporterGENTILE GABRIELLA·Filed 2007·Application pending·0 cites
- 4045US2009325993A1GLYT1 Transporter Inhibitors and Uses Thereof in Treatment of Neurological and Neuropsychiatric DisordersAHMAD NADIA MAMOONA·Filed 2008·Application pending·0 cites
- 4144US2006040937A1N-aroyl cyclic amines as orexin receptor antagonistsGLAXO GROUP LTD·Filed 2003·Application pending·0 cites
- 4243US11400081B2CompoundsUNIV SHEFFIELD·Filed 2018·Granted Aug 2, 2022·0 cites·21 claims
- 4343US2010029700A11-(2-aryl-2-oxoethyl)-3-phenyl-1, 4-diazaspiro [4.5]dec-3-en-2-one derivatives and their use as glycine transporter inhibitorsBRANCH CLIVE LESLIE·Filed 2007·Application pending·0 cites
- 4443US2009326027A1N-Phenyl-2-0X0-1,4-Diazaspiro [4.5] Dec-3-EN-1-YL Acetamide Derivatives And Their Use As Glycine Transporter InhibitorsCOULTON STEVEN·Filed 2007·Application pending·0 cites
- 4543US2009227629A1Compounds having activity at the glycine transporter glyt1 and uses thereofGLAXO GROUP LTD·Filed 2007·Application pending·0 cites
- 4643US2009062360A1Compounds Which Inhibit the Glycine Transporter and Uses ThereofCOULTON STEVEN·Filed 2007·Application pending·0 cites
- 4742US2010016374A1Compounds Which Inhibit the Glycine Transporter and Uses ThereofCOULTON STEVEN·Filed 2007·Application pending·0 cites
- 4841US2009318447A1N-[6-(4-morpholinyl)-3-pyridinyl]-2-(tetrahydro-2h-pyran-4-yl)-n-[(1--4-piperidinyl) methyl] acetamide derivatives and related compounds as glyt1 transport inhibitors for the treatment of neurological disorders such as schizophreniaNASH DAVID JOHN·Filed 2005·Application pending·0 cites
- 4941US2022023281A1Heterocyclic spiro-compounds as am2 receptor inhibitorsUNIV SHEFFIELD·Filed 2019·Application pending·0 cites
- 5041US2008103173A1Compounds Having Activity At Nk3 Receptor And Uses Thereof In MedicineSMITHKLINE BEECHAM CORP·Filed 2005·Application pending·0 cites
Showing the top 50 of 68 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Roderick Alan Porter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →